Chandra Bhagat Pharma Limited is an India-based pharmaceutical company. The Company is engaged in the business of marketing pharmaceutical critical care and health care products. The Company is focused on marketing pharmaceutical formulations and products in the domestic and international market through its own distribution network and sales under its own brand. It focuses on Injection - IV (Intravenous) and IM (Intramuscular), tablets and capsules supplied to hospitals and health care centers for critical diseases. The Company also deals in importing and supplying active pharmaceutical ingredients (API) and its intermediates. The Company also has its presence in the therapeutic categories for formulations such as anti-cancer (oncology), antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, antifungal, antiviral, pediatrics, cardiology, nephrology, and neurology. It is also engaged in promoting and marketing of API in India.As of 26 May 2026, Chandra Bhagat Pharma Limited share price is ₹40.00. The stock opened at ₹38.00, compared to its previous close of ₹38.00. During today's trading session, Chandra Bhagat Pharma Limited share price moved in the range of ₹38.00 to ₹41.80, with an average price of ₹39.90 for the day. Looking at its last 52-week, the stock has touched a low of ₹38.00 and a high of ₹41.80.
The market capitalization of Chandra Bhagat Pharma Limited is ₹29 Crs, with a P/E ratio of 45.9 and a dividend yield of 0.00%.